Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Asthma

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 146 articles:
HTML format
Text format



Single Articles


    February 2018
  1. TURNER S, Fielding S, Devereux G
    First trimester fetal size and prescribed asthma medication at 15 years of age.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  2. NAGAKUMAR P, Gambir N, Sanghani N, Hall P, et al
    Role of a prolonged inpatient admission when evaluating children with problematic severe asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    



  3. "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel a
    Eur Respir J. 2018;51.
    PubMed     Text format    


  4. LAVIGNE E, Belair MA, Rodriguez Duque D, Do MT, et al
    Effect modification of perinatal exposure to air pollution and childhood asthma incidence.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01884-2017.
    PubMed     Text format     Abstract available


  5. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  6. GRZESKOWIAK LE, Smithers LG, Grieger JA, Bianco-Miotto T, et al
    Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  7. COUMOU H, Westerhof GA, de Nijs SB, Zwinderman AH, et al
    Predictors of accelerated decline in lung function in adult-onset asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  8. PEKKANEN J, Valkonen M, Taubel M, Tischer C, et al
    Indoor bacteria and asthma in adults: a multicentre case-control study within ECRHS II.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    January 2018
  9. MANISCALCO M, Paris D, Melck DJ, Molino A, et al
    Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study.
    Eur Respir J. 2018 Jan 18. pii: 13993003.01825-2017.
    PubMed     Text format    


  10. JORUP C, Lythgoe D, Bisgaard H
    Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  11. SULAIMAN I, Greene G, MacHale E, Seheult J, et al
    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  12. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  13. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    December 2017
  14. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  15. BOUSQUET J, Brusselle G, Buhl R, Busse WW, et al
    Care pathways for the selection of a biologic in severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  16. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  17. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  18. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  19. ANDRIANJAFIMASY M, Zerimech F, Akiki Z, Huyvaert H, et al
    Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  20. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  21. JOCHMANN A, Artusio L, Jamalzadeh A, Nagakumar P, et al
    Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    November 2017
  22. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  23. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  24. BOURDIN A, Molinari N, Vachier I, Pahus L, et al
    Mortality: a neglected outcome in OCS-treated severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    October 2017
  25. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  26. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  27. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  28. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  29. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    PubMed     Text format    


  30. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  31. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  32. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  33. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  34. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  35. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  36. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed     Text format    


  37. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  38. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  39. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    August 2017
  40. SIN DD, Leung JM, Wechsler ME
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  41. TOMMOLA M, Ilmarinen P, Tuomisto LE, Kankaanranta H, et al
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  42. THOMSON NC, Chanez P
    How effective is bronchial thermoplasty for severe asthma in clinical practice?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  43. CHUPP G, Laviolette M, Cohn L, McEvoy C, et al
    Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  44. BATEMAN ED, Guerreros AG, Brockhaus F, Holzhauer B, et al
    Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  45. PRETOLANI M, Soussan D, Poirier I, Thabut G, et al
    Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  46. ERJ August Podcast: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  47. MICHILS A, Haccuria A, Michiels S, Van Muylem A, et al
    Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    June 2017
  48. CARPAIJ OA, Nieuwenhuis MAE, Koppelman GH, van den Berge M, et al
    Childhood factors associated with complete and clinical asthma remission at 25 and 49 years.
    Eur Respir J. 2017;49.
    PubMed     Text format    



  49. "The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts." Louise Fleming, Clare Murray, Aruna T. Bansal, Simone Hashimoto, Hans Bisgaard, Andrew Bush, Urs Frey, Gunilla Hedlin, Florian Singer, Wim M. va
    Eur Respir J. 2017;49.
    PubMed     Text format    



  50. "Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort." Dominick E. Shaw, Ana R. Sousa, Stephen J. Fowler, Louise J. Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T. Bansal, Elisabeth H. Bel,
    Eur Respir J. 2017;49.
    PubMed     Text format    


  51. AL SALLAKH MA, Vasileiou E, Rodgers SE, Lyons RA, et al
    Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  52. DUNICAN EM, Fahy JV
    Asthma and corticosteroids: time for a more precise approach to treatment.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  53. BERTHON BS, Gibson PG, Wood LG, MacDonald-Wicks LK, et al
    A sputum gene expression signature predicts oral corticosteroid response in asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  54. BUHL R, Humbert M, Bjermer L, Chanez P, et al
    Severe eosinophilic asthma: a roadmap to consensus.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  55. MIRAVITLLES M
    Diagnosis of asthma-COPD overlap: the five commandments.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  56. BOUSQUET J, Chavannes NH, Guldemond N, Haahtela T, et al
    Realising the potential of mHealth to improve asthma and allergy care: how to shape the future.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  57. MCDONALD VM, Gibson PG
    "To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  58. HIMES BE, Ortega VE
    Making progress toward understanding the genetic architecture of asthma in the most affected US ethnic group.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  59. HERBERT C, Kumar RK
    Ambient air pollution and asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  60. MIRAVITLLES M, Alvarez-Gutierrez FJ, Calle M, Casanova C, et al
    Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  61. EDWARDS MR, Saglani S, Schwarze J, Skevaki C, et al
    Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  62. COSIO BG, Perez de Llano L, Lopez Vina A, Torrego A, et al
    Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  63. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Differences between asthma-COPD overlap syndrome and adult-onset asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  64. MASEFIELD S, Edwards J, Hansen K, Hamerlijnck D, et al
    The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP).
    Eur Respir J. 2017;49.
    PubMed     Text format    


  65. PAPADOPOULOS NG, Androutsopoulou A, Akdis C, Dahlen SE, et al
    Asthma research in Europe: a transformative agenda for innovation and competitiveness.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  66. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  67. THOMSON NC
    Asthma and smoking-induced airway disease without spirometric COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  68. AZAD MB, Vehling L, Lu Z, Dai D, et al
    Breastfeeding, maternal asthma and wheezing in the first year of life: a longitudinal birth cohort study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  69. BONTEN TN, Kasteleyn MJ, de Mutsert R, Hiemstra PS, et al
    Defining asthma-COPD overlap syndrome: a population-based study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  70. SIMPSON AJ, Honkoop PJ, Kennington E, Snoeck-Stroband JB, et al
    Perspectives of patients and healthcare professionals on mHealth for asthma self-management.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  71. BERAIR R, Hartley R, Mistry V, Sheshadri A, et al
    Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  72. YAN Q, Brehm J, Pino-Yanes M, Forno E, et al
    A meta-analysis of genome-wide association studies of asthma in Puerto Ricans.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  73. HTET TD, Teede HJ, de Courten B, Loxton D, et al
    Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    March 2017
  74. GRAS D, Martinez-Anton A, Bourdin A, Garulli C, et al
    Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  75. MUNOZ-CANO R, Torrego A, Bartra J, Sanchez-Lopez J, et al
    Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  76. DEBRAY MP, Dombret MC, Pretolani M, Thabut G, et al
    Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  77. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  78. SCAGNOLARI C, Midulla F, Nenna R, Papoff P, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  79. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  80. STERK PJ
    A good asthma catch by professional fishing.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  81. BARALDO S, Papi A, Saetta M, Contoli M, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  82. REINKE SN, Gallart-Ayala H, Gomez C, Checa A, et al
    Metabolomics analysis identifies different metabotypes of asthma severity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  83. PAPI A, Saetta M, Fabbri L
    Severe asthma: phenotyping to endotyping or vice versa?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  84. KUO CS, Pavlidis S, Loza M, Baribaud F, et al
    T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  85. BRUMPTON B, Mai XM, Langhammer A, Laugsand LE, et al
    Prospective study of insomnia and incident asthma in adults: the HUNT study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  86. ZOLLER B, Pirouzifard M, Memon AA, Sundquist J, et al
    Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  87. BAHMER T, Waschki B, Schatz F, Herzmann C, et al
    Physical activity, airway resistance and small airway dysfunction in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  88. GRIGG J
    Tiotropium in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  89. ELLWOOD P, Asher MI, Billo NE, Bissell K, et al
    The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  90. ERJ January Podcast: the BioSHaRE approach to understanding of the effects of air pollution on asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    December 2016
  91. GAGA M, Zervas E, Humbert M
    Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
    Eur Respir J. 2016;48:1538-1540.
    PubMed     Text format    


    November 2016
  92. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2016 Nov 11. pii: ERJ-00969-2016. doi: 10.1183/13993003.00969-2016
    PubMed     Text format     Abstract available


  93. HAMELMANN E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, et al
    A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01100-2016. doi: 10.1183/13993003.01100-2016.
    PubMed     Text format     Abstract available


  94. LEZMI G, Galmiche-Rolland L, Rioux S, Jaubert F, et al
    Mast cells are associated with exacerbations and eosinophilia in children with severe asthma.
    Eur Respir J. 2016;48:1320-1328.
    PubMed     Text format     Abstract available


  95. WILSON SJ, Ward JA, Sousa AR, Corfield J, et al
    Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.
    Eur Respir J. 2016;48:1307-1319.
    PubMed     Text format     Abstract available


  96. FLEMING L, Saglani S, Bush A
    Asthma attacks: should we nail our colours to the mast (cell)?
    Eur Respir J. 2016;48:1261-1264.
    PubMed     Text format    


    October 2016
  97. CAI Y, Zijlema WL, Doiron D, Blangiardo M, et al
    Ambient air pollution, traffic noise and adult asthma prevalence: a BioSHaRE approach.
    Eur Respir J. 2016 Oct 20. pii: ERJ-02127-2015. doi: 10.1183/13993003.02127-2015
    PubMed     Text format     Abstract available


  98. PILLAI P, Chan YC, Wu SY, Ohm-Laursen L, et al
    Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
    Eur Respir J. 2016 Oct 20. pii: ERJ-01501-2015. doi: 10.1183/13993003.01501-2015
    PubMed     Text format     Abstract available


  99. CHEN YC, Liou TH, Chen PC, Chiang BL, et al
    Growth trajectories and asthma/rhinitis in children: a longitudinal study in Taiwan.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00741-2016. doi: 10.1183/13993003.00741-2016
    PubMed     Text format     Abstract available


  100. CHEN W, Lynd LD, FitzGerald JM, Marra CA, et al
    Excess medical costs in patients with asthma and the role of comorbidity.
    Eur Respir J. 2016 Oct 6. pii: ERJ-01141-2016. doi: 10.1183/13993003.01141-2016.
    PubMed     Text format     Abstract available


  101. SCHWARZE J, Fitch PM, Heimweg J, Errington C, et al
    Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00841-2016. doi: 10.1183/13993003.00841-2016.
    PubMed     Text format    


  102. MAGNUS MC, Haberg SE, Magnus P, Engeland A, et al
    Pre-eclampsia and childhood asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00673-2016. doi: 10.1183/13993003.00673-2016.
    PubMed     Text format     Abstract available


  103. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1247-1248.
    PubMed     Text format    


  104. GAO YH, Guan WJ, Chen RC, Zhang GJ, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1246-1247.
    PubMed     Text format    


  105. POYNTER ME, Irvin CG
    Interleukin-6 as a biomarker for asthma: hype or is there something else?
    Eur Respir J. 2016;48:979-981.
    PubMed     Text format    


  106. HAMBLETON K, Pavord ID
    What can we learn from blood granulocyte patterns in patients with asthma?
    Eur Respir J. 2016;48:976-978.
    PubMed     Text format    


    September 2016
  107. TOMMOLA M, Ilmarinen P, Tuomisto LE, Haanpaa J, et al
    The effect of smoking on lung function: a clinical study of adult-onset asthma.
    Eur Respir J. 2016 Sep 22. pii: ERJ-00850-2016. doi: 10.1183/13993003.00850-2016
    PubMed     Text format     Abstract available


  108. VAN DEN WIJNGAART LS, Roukema J, Merkus PJ
    Monitoring asthma: no matter how?
    Eur Respir J. 2016;48:614-6.
    PubMed     Text format    


  109. ROBINSON DS
    Assessing severe asthma.
    Eur Respir J. 2016;48:611-3.
    PubMed     Text format    


  110. GRAS D, Chanez P
    New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
    Eur Respir J. 2016;48:608-10.
    PubMed     Text format    


  111. AHMADIZAR F, Vijverberg SJ, Arets HG, de Boer A, et al
    Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00766-2016. doi: 10.1183/13993003.00766-2016.
    PubMed     Text format     Abstract available


    August 2016
  112. ILMARINEN P, Tuomisto LE, Niemela O, Danielsson J, et al
    Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma.
    Eur Respir J. 2016 Aug 18. pii: ERJ-02198-2015. doi: 10.1183/13993003.02198-2015
    PubMed     Text format     Abstract available


  113. NADIF R, Siroux V, Boudier A, le Moual N, et al
    Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00336-2016. doi: 10.1183/13993003.00336-2016.
    PubMed     Text format     Abstract available


  114. LEHTIMAKI L, Csonka P, Makinen E, Isojarvi J, et al
    Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00699-2016. doi: 10.1183/13993003.00699-2016.
    PubMed     Text format     Abstract available


  115. KING GG, Thamrin C
    Complex lung function in severe asthma: seeing is believing.
    Eur Respir J. 2016;48:294-6.
    PubMed     Text format    


  116. PETERS MC, Fahy JV
    Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
    Eur Respir J. 2016;48:291-3.
    PubMed     Text format    


  117. BARALDO S, Turato G, Cosio MG, Saetta M, et al
    Which CD8+ T-cells in asthma? Attacking or defending?
    Eur Respir J. 2016;48:287-90.
    PubMed     Text format    


    July 2016
  118. USEMANN J, Fuchs O, Anagnostopoulou P, Korten I, et al
    Predictive value of exhaled nitric oxide in healthy infants for asthma at school age.
    Eur Respir J. 2016 Jul 7. pii: ERJ-00439-2016. doi: 10.1183/13993003.00439-2016.
    PubMed     Text format    



  119. "Tidal flow variability measured by impedance pneumography relates to childhood asthma risk." Ville-Pekka Seppa, Anna S. Pelkonen, Anne Kotaniemi-Syrjanen, Jari Viik, Mika J. Makela and L. Pekka Malmberg. Eur Respir J 2016; 47: 1687-1696.
    Eur Respir J. 2016;48:285.
    PubMed     Text format    


    June 2016
  120. VAN DER MEER AN, Pasma H, Kempenaar-Okkema W, Pelinck JA, et al
    A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00220-2016. doi: 10.1183/13993003.00220-2016
    PubMed     Text format     Abstract available


  121. SIN DD, Miravitlles M, Mannino DM, Soriano JB, et al
    What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00436-2016. doi: 10.1183/13993003.00436-2016
    PubMed     Text format     Abstract available


  122. DORAN E, Choy DF, Shikotra A, Butler CA, et al
    Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00400-2015. doi: 10.1183/13993003.00400-2015
    PubMed     Text format     Abstract available


  123. FISHER JA, Puett RC, Hart JE, Camargo CA Jr, et al
    Particulate matter exposures and adult-onset asthma and COPD in the Nurses' Health Study.
    Eur Respir J. 2016 Jun 10. pii: ERJ-00845-2015. doi: 10.1183/13993003.00845-2015
    PubMed     Text format    



  124. "Asthma inhaler adherence determinants in adults: systematic review of observational data." Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994-1018.
    Eur Respir J. 2016;47:1892.
    PubMed     Text format    


    May 2016
  125. DEN OTTER I, Willems LN, van Schadewijk A, van Wijngaarden S, et al
    Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells.
    Eur Respir J. 2016 May 26. pii: ERJ-01525-2015. doi: 10.1183/13993003.01525-2015
    PubMed     Text format     Abstract available


  126. DUCHARME FM, Gagnon R, Benard B, Tse SM, et al
    Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids.
    Eur Respir J. 2016 May 26. pii: ERJ-00014-2016. doi: 10.1183/13993003.00014-2016
    PubMed     Text format    


  127. VASBINDER EC, Goossens LM, Rutten-van Molken MP, de Winter BC, et al
    e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial.
    Eur Respir J. 2016 May 26. pii: ERJ-01698-2015. doi: 10.1183/13993003.01698-2015
    PubMed     Text format     Abstract available


  128. CHIH AH, Chen YC, Tu YK, Huang KC, et al
    Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study.
    Eur Respir J. 2016 May 12. pii: ERJ-00226-2016. doi: 10.1183/13993003.00226-2016
    PubMed     Text format     Abstract available


  129. SVENNINGSEN S, Nair P, Guo F, McCormack DG, et al
    Is ventilation heterogeneity related to asthma control?
    Eur Respir J. 2016 May 12. pii: ERJ-00393-2016. doi: 10.1183/13993003.00393-2016
    PubMed     Text format     Abstract available


    April 2016
  130. LUM S, Stocks J
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1292-3.
    PubMed     Text format    


  131. HULS A, Kramer U, Schuster A, Gappa M, et al
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1290-2.
    PubMed     Text format    


  132. BOUSQUET J, Barbara C, Bateman E, Bel E, et al
    AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
    Eur Respir J. 2016;47:1028-33.
    PubMed     Text format    


  133. DIZIER MH, Nadif R, Margaritte-Jeannin P, Barton SJ, et al
    Interaction between the DNAH9 gene and early smoke exposure in bronchial hyperresponsiveness.
    Eur Respir J. 2016;47:1072-81.
    PubMed     Text format     Abstract available


    March 2016
  134. KOLAHIAN S, Oz HH, Zhou B, Griessinger CM, et al
    The emerging role of myeloid-derived suppressor cells in lung diseases.
    Eur Respir J. 2016;47:967-77.
    PubMed     Text format     Abstract available


    February 2016
  135. CONTOLI M, Bellini F, Morandi L, Forini G, et al
    Assessing small airway impairment in mild-to-moderate smoking asthmatic patients.
    Eur Respir J. 2016 Feb 11. pii: ERJ-01708-2015. doi: 10.1183/13993003.01708-2015
    PubMed     Text format    


  136. MOSS RB
    Treating allergic bronchopulmonary aspergillosis: the way forward.
    Eur Respir J. 2016;47:385-7.
    PubMed     Text format    


  137. AGUSTI A, Bel E, Thomas M, Vogelmeier C, et al
    Treatable traits: toward precision medicine of chronic airway diseases.
    Eur Respir J. 2016;47:410-9.
    PubMed     Text format     Abstract available


  138. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


  139. GARDEN FL, Simpson JM, Mellis CM, Marks GB, et al
    Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis.
    Eur Respir J. 2016;47:499-509.
    PubMed     Text format     Abstract available


    January 2016
  140. GOEMINNE PC, De Soyza A
    Bronchiectasis: how to be an orphan with many parents?
    Eur Respir J. 2016;47:10-3.
    PubMed     Text format    


  141. SHAHEEN SO, Macdonald-Wallis C, Lawlor DA, Henderson AJ, et al
    Hypertensive disorders of pregnancy, respiratory outcomes and atopy in childhood.
    Eur Respir J. 2016;47:156-65.
    PubMed     Text format     Abstract available


  142. GABROVSKA M, Lacombe E, Bruyneel M, Ninane V, et al
    Acute bronchospasm during passive exposure to bronchial provocation tests.
    Eur Respir J. 2016;47:320-2.
    PubMed     Text format    


    December 2015
  143. POPOVIC M, Rusconi F, Zugna D, Galassi C, et al
    Prenatal exposure to antibiotics and wheezing in infancy: a birth cohort study.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00315-2015. doi: 10.1183/13993003.00315-2015.
    PubMed     Text format     Abstract available


    October 2015
  144. COX DW, Mullane D, Zhang GC, Turner SW, et al
    Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.
    Eur Respir J. 2015 Oct 22. pii: ERJ-00397-2015. doi: 10.1183/13993003.00397-2015
    PubMed     Text format     Abstract available


  145. YAMMINE S, Schmidt A, Sutter O, Fouzas S, et al
    Functional evidence for continued alveolarisation in former preterms at school age?
    Eur Respir J. 2015 Oct 22. pii: ERJ-00478-2015. doi: 10.1183/13993003.00478-2015
    PubMed     Text format     Abstract available


    July 2015
  146. GAUVREAU GM, El-Gammal AI, O'Byrne PM
    Allergen-induced airway responses.
    Eur Respir J. 2015 Jul 23. pii: ERJ-00536-2015. doi: 10.1183/13993003.00536-2015
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: